Market revenue in 2023 | USD 32.5 million |
Market revenue in 2030 | USD 58.2 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Surgery |
Fastest growing segment | Intralesional injections |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiotherapy (RT), Intralesional injections, Intravenous Medications, Chemical peeling treatment, Surgery, Topical chemotherapy, Oral Medications |
Key market players worldwide | Bausch Health Companies Inc, Almirall SA, Genentech, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Dr Reddy's Laboratories Ltd ADR, Taro Pharmaceuticals, Accord Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to basal cell carcinoma treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 36% in 2023. Horizon Databook has segmented the Middle East & Africa basal cell carcinoma treatment market based on radiotherapy (rt), intralesional injections, intravenous medications, chemical peeling treatment, surgery, topical chemotherapy, oral medications covering the revenue growth of each sub-segment from 2018 to 2030.
The basal cell carcinoma treatment market in the Middle East and Africa (MEA) is witnessing steady growth due to several factors, such as increasing incidence of skin cancer, rising awareness about early detection, advancements in diagnostic technologies, and growing initiatives for skin cancer prevention & control.
The rise in skin cancer incidence can be attributed to changing lifestyles, insufficient sun protection measures, and environmental factors. The MEA offers significant opportunities for growth in the basal cell carcinoma treatment market, mainly due to the need for more structured screening programs in less developed African countries.
However, countries such as the UAE, Morocco, and South Africa have initiated organized cancer screening efforts in recent years. Furthermore, collaborations between companies and government bodies to facilitate these screenings are expected to propel market expansion.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa basal cell carcinoma treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa basal cell carcinoma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account